Cardiovascular Diabetology

OCTOBER 25, 2024

Atherosclerotic cardiovascular diseases remain the leading cause of mortality in diabetic patients, with endothelial cell (EC) dysfunction serving as the initiating step of atherosclerosis, which is exacerbate.

Atherosclerosis 52

Atherosclerosis Diabetes Cardiovascular Disease Research 52

Journal of the American Heart Association

FEBRUARY 19, 2025

This study examines the relationship between tHcy, HF overall, and HF subtype (HF with preserved ejection fraction [HFpEF] and HF with reduced ejection fraction) in the MultiEthnic Study of Atherosclerosis cohort.MethodsMultiEthnic Study of Atherosclerosis participants with baseline tHcy and HF data were included (N=6765).

Atherosclerosis 75

Atherosclerosis Heart Failure Preserved Ejection Fraction Diabetes 75

Cardiovascular Diabetology

MARCH 28, 2024

Diabetes-induced trained immunity contributes to the development of atherosclerosis and its complications. This study aimed to investigate in humans whether epigenetic signals involved in immune cell activatio.

Diabetes 80

Diabetes Atherosclerosis Research 80

Stroke Journal

JANUARY 30, 2025

Introduction:Prior studies have shown the association between oral infection, white matter hyperintensity (WMH), a marker of cerebral small vessel disease (CSVD), and asymptomatic intracranial atherosclerosis (ICAS). However, the impact of preventative oral behavior such as dental flossing is unknown. The log WMH volume was higher (9.50.85

Atherosclerosis 75

Atherosclerosis Stenosis Education Risk Factors 75

Journal of Cardiovascular Pharmacology

NOVEMBER 16, 2023

Abstract: Worldwide, type 2 diabetes is predominant form of diabetes, and it is mainly affected by the environment. In the process of diabetes onset and intergenerational transmission, the genetic structure of the individual is not directly changed but is regulated by epigenetics.

Atherosclerosis 40

Atherosclerosis Diabetes Cardiovascular Disease Article 40

Cardiovascular Diabetology

FEBRUARY 25, 2025

Diabetic panvascular disease (DPD) is the leading clinical complication of diabetes mellitus (DM), characterized by atherosclerosis across multiple organ vessels. It is a major cause of high disability and mor.

Diabetes 59

Diabetes Atherosclerosis Research 59

Circulation

NOVEMBER 11, 2024

Recent studies implicate EndMT in atherosclerosis development. Diabetes is associated with both EndMT as well as accelerated atherosclerosis. Experimental evidence supports the use of epigenetic drugs that act on relevant epigenetic mechanisms to attenuate atherosclerosis. RNA sequencing was performed in this setting.

Atherosclerosis 40

Atherosclerosis Diabetes Aortic Cardiovascular Disease 40

Frontiers in Cardiovascular Medicine

FEBRUARY 4, 2024

Background Carotid artery atherosclerosis is a major cause of ischemic stroke, and ischemic stroke is the leading cause of morbidity and mortality worldwide. Unfortunately, the reason for the build-up of atherosclerosis plaque is unknown. Moreover, there was an increased miRNA-29c level in patients with cerebral stroke.

Plaque 64

Plaque Diabetes Atherosclerosis Stroke 64

American College of Cardiology

FEBRUARY 14, 2024

Type 2 diabetes mellitus (T2DM) is a highly prevalent risk factor that likely contributes to this disparity. The risk of atherosclerotic cardiovascular disease (ASCVD) is approximately twofold higher for South Asian (SA) adults than for adults from other racial and ethnic groups.

Diabetes 64

Diabetes Atherosclerosis Risk Factors Cardiovascular Disease 64

Cardiovascular Diabetology

NOVEMBER 18, 2024

Individuals with type 1 diabetes are at increased risk of accelerated atherosclerosis, causing coronary artery disease (CAD). The underlying mechanisms remain unclear, but new theories proposed are damage of g.

Coronary Artery Disease 59

Coronary Artery Disease Diabetes Atherosclerosis Research 59

Medical Xpress - Cardiology

AUGUST 15, 2024

Besides other problems like diabetes and atherosclerosis, saturated fats have also been linked to life-threatening arrhythmias. Over the past few decades, scientists have generated a pile of evidence suggesting that a diet rich in saturated fats is enough to cause heart diseases.

Arrhythmia 81

Arrhythmia Diet Atherosclerosis Heart Disease 81

Heart BMJ

MARCH 26, 2025

Methods We retrospectively analysed data from 5188 participants in the Atherosclerosis Risk in Communities Study who were free from heart failure at baseline, including 802 individuals with a history of myocardial infarction. Patients with pulse pressure ≥68 mm Hg had a 3.83-fold m/s had a 2.10-fold

Aortic valve 52

Aortic valve Myocardial Infarction Preserved Ejection Fraction Heart Failure 52

Dr. Paddy Barrett

DECEMBER 13, 2024

ApoB Atherosclerosis, by definition, is caused by the retention of an ApoB lipid particle in the artery wall. This retained particle then sets off an inflammatory cascade, which ultimately results in the formation of atherosclerosis 1. Mechanism of atherosclerosis formation. Relationship of BMI and Risk Of Diabetes.

Heart Disease 98

Heart Disease BMI Diabetes Cardiovascular Disease 98

Cardiovascular Diabetology

NOVEMBER 18, 2024

Both insulin resistance and hyperglycemia are important risk factors for atherosclerosis. While the characteristics of atherosclerosis are obviously different according to established diabetes, little has been.

Diabetes 52

Diabetes Atherosclerosis Risk Factors Research 52

Circulation

NOVEMBER 11, 2024

Introduction:It remains uncertain whether dietary supplementation of marine n-3 polyunsaturated fatty acids (PUFAs) improves atherosclerosis and lipoprotein subclasses in patients with type 2 diabetes (T2D). Circulation, Volume 150, Issue Suppl_1 , Page A4142898-A4142898, November 12, 2024. day) or low-dose (1.5g/day)

Atherosclerosis 40

Atherosclerosis Diabetes Plaque Cholesterol 40

Journal of Clinical Investigation - Cardiology

JANUARY 16, 2024

Gestational diabetes is a common medical complication of pregnancy that is associated with adverse perinatal outcomes and an increased risk of metabolic diseases and atherosclerosis in adult offspring. The mechanisms responsible for this delayed pathological transmission remain unknown.

Diabetes 52

Diabetes Atherosclerosis Outcomes 52

Circulation: Genomic and Precision Medicine

NOVEMBER 28, 2023

BACKGROUND:Individuals with type 2 diabetes (T2D) have an increased risk of coronary artery disease (CAD), but questions remain about the underlying pathology. Circulation: Genomic and Precision Medicine, Ahead of Print.

Atherosclerosis 40

Atherosclerosis Diabetes Plaque Coronary Artery Disease 40

Cardiovascular Diabetology

JULY 4, 2024

Atherogenic index of plasma (AIP) is a non-traditional lipid parameter that can reflect the burden of atherosclerosis. A lipid profile resembling atherosclerosis emerged during pregnancy. Although lipid metabo.

Atherosclerosis 59

Atherosclerosis Diabetes Research 59

Cardiovascular Diabetology

JULY 3, 2024

The abnormal low-density protein cholesterol (LDL-C) level in the development of atherosclerosis is often comorbid in individuals with type 2 diabetes mellitus(T2DM). This study aimed to investigate the aggrav.

Cholesterol 45

Cholesterol Diabetes Atherosclerosis Plaque 45

Frontiers in Cardiovascular Medicine

DECEMBER 9, 2024

Elevated RLP-C levels were associated with high triglyceride concentrations, diabetes mellitus, and increased risk of revascularization.ConclusionsThis study illustrated the atherogenic impact of RLP-C in CAD patients. High RLP-C levels increased the risk of revascularization.

Cholesterol 98

Cholesterol Coronary Artery Disease Atherosclerosis Diabetes 98

European Journal of Heart Failure

NOVEMBER 3, 2024

Development and validation of a machine-learning approach to identify diabetic cardiomyopathy. Aims Abnormalities in specific echocardiographic parameters and cardiac biomarkers have been reported among individuals with diabetes. Participants with (vs.

Cardiomyopathy 40

Cardiomyopathy Diabetes Biomarkers Atherosclerosis 40

Journal of the American Heart Association

APRIL 3, 2025

Multivariable logistic regression showed that patients with largeartery atherosclerosis pathogenesis, diabetes, higher admission National Institutes of Health Stroke Scale scores, and higher 90day modified Rankin Scale had significantly lower odds of RTW.

Stroke 45

Stroke Strokes Atherosclerosis Diabetes 45

Circulation: Heart Failure

MARCH 8, 2024

The prevalence of HF risk factors was high: hypertension, 61.9%; former or current smoking, 53.7%; obesity 34.8%; diabetes; 24.7%; and chronic kidney disease; 22%. Results:Median age was 73 (25th–75th percentile 67–81) years, 53.2% were female, 25.6% were Black, 12.8% were Chinese, and 40.0% were White.

Heart Failure 40

Heart Failure Atherosclerosis Kidney Disease Risk Factors 40

DAIC

MARCH 6, 2024

The CAD Staging System is a noninvasive imaging-based investigational software device that analyzes important and actionable features of coronary atherosclerosis, stenosis and ischemia. Food and Drug Administration ( FDA ) for its Coronary Artery Disease ( CAD ) Staging System.

Heart Disease 105

Heart Disease Heart attacks Heart Attack Technology 105

Frontiers in Cardiovascular Medicine

FEBRUARY 7, 2024

At the patient level, those with reduced CFR showed a significantly higher prevalence of diffused atherosclerosis (41% vs. 23%; P  < 0.001) and higher FAI (−75.5 HU In the patient-level analysis, obstructive CAD, diffused atherosclerosis, and FAI were independently linked with CFR. Results We detected a decrease in CFR (<2.5)

Coronary Artery Disease 64

Coronary Artery Disease Atherosclerosis Plaque Stenosis 64

Cardiometabolic Health Congress

NOVEMBER 25, 2024

Diabetes Management: Gain insights into precision medicine, advanced insulin therapies, and continuous glucose monitoring (CGM) for cardiovascular risk assessment. Dyslipidemia, Atherosclerosis & Thrombosis: Explore non-statin therapies, strategies for managing hypertriglyceridemia, and new guidance on lipoprotein(a) management.

CME 52

CME Obesity Certification Education 52

Cardiometabolic Health Congress

JULY 25, 2024

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. The robust conference agenda begins with FDA updates and advancements in cardiorenal metabolic care.

Education 100

Education Innovation Risk Factors Obesity 100

American College of Cardiology

SEPTEMBER 18, 2024

cobalt, copper, zinc) are associated with increased coronary artery calcification (CAC) and are comparable to traditional cardiovascular disease risk factors like smoking and diabetes, according to results from the Multi-Ethnic Study of Atherosclerosis (MESA) published in JACC. Urinary levels of non-essential (i.e.,

Atherosclerosis 43

Atherosclerosis Risk Factors Cardiovascular Disease Diabetes 43

Frontiers in Cardiovascular Medicine

JANUARY 10, 2024

Coronary heart disease is a narrowing or obstruction of the vascular cavity caused by atherosclerosis of the coronary arteries, which leads to myocardial ischemia and hypoxia. Sodium-glucose cotransporter 2 (SGLT2) inhibitor is a new oral glucose-lowering agent used in the treatment of diabetes in recent years.

Heart Disease 59

Heart Disease Stents Stent Atherosclerosis 59

Stroke Journal

FEBRUARY 1, 2024

Background:The association between left ventricular injury (LVI) detected by cardiac magnetic resonance imaging (CMR) and the risk of a subsequent ischemic stroke is unknown.Methods:We studied stroke-free participants in the Multi-Ethnic Study of Atherosclerosis study who underwent a steady-state free precession CMR at Exam 5 (2010-2012).

Atherosclerosis 40

Atherosclerosis Stroke Strokes Atrial Fibrillation 40

The British Journal of Cardiology

FEBRUARY 20, 2024

One of the assessments for coronary atherosclerosis during cardiac computed tomography (CT) is coronary artery calcium (CAC) scoring. We found that a history of hypertension and diabetes are independent determinants of having a high-risk CAC score. This study involved a total of 1,129 female patients from a single centre.

Blood Pressure 52

Blood Pressure Chest Pain Atherosclerosis Diabetes 52

Frontiers in Cardiovascular Medicine

JANUARY 18, 2024

However, due to the distinct biological functions of ASCs from different origins or donors with varing health statuses (such as aging, diabetes, or atherosclerosis), the heterogeneity of ASCs deserves more attention. Exosomes from ASCs also play an indispensable role in this process.

Heart Disease 64

Heart Disease Myocardial Infarction Transplant Atherosclerosis 64

DAIC

AUGUST 15, 2024

This happens more commonly in people with metabolic risk factors such as obesity, diabetes, or high triglycerides. guidelines may overlook people who are at higher risk of developing atherosclerosis despite normal metabolic health markers. But even people without these conditions can have discordance. population.

Heart Disease 105

Heart Disease Research Cholesterol Public Health 105

Journal of the American Heart Association

FEBRUARY 26, 2025

BackgroundPlaque progression (PP) is critical between subclinical atherosclerosis and plaque rupture. P=0.006), especially in diabetic patients (Pearsonr=0.58,P&lt;0.001). Journal of the American Heart Association, Ahead of Print. months, PP was found in 65 lesions (44.5%), and mean changes in percent atheroma volume were 4.1%10.2%.

Ultrasound 56

Ultrasound Plaque Cholesterol Coronary Artery Disease 56

Frontiers in Cardiovascular Medicine

DECEMBER 5, 2024

The fundamental role of qualitative alterations of lipoproteins in the early development of atherosclerosis has been widely demonstrated. However, the corresponding studies are scarcer in the field of ischemic stroke, despite carotid arteriosclerosis progression underlies at least 20% of ischemic strokes.

Circulation 40

Circulation Stroke Strokes Atherosclerosis 40

Cardiometabolic Health Congress

OCTOBER 25, 2024

Keynote speaker and atherosclerosis expert Peter Libby, MD , captivated the audience with an update on his research into inflammation and atherosclerosis. He discussed therapeutic options not only for treating atherosclerosis but also for preventing cardiovascular disease.

CME 64

CME Innovation Education Atherosclerosis 64

Cardiometabolic Health Congress

AUGUST 14, 2024

The focus will be on the intricate interplay between cardiorenal and metabolic conditions, such as type 2 diabetes, cardiovascular disease, and chronic kidney disease, driven by lifestyle and health factors. Aronne, MD Expert Perspectives on Initiating and Maintaining Insulin Therapy in Type 2 Diabetes Patients Jay H.

CME 72

CME Education Diabetes Innovation 72